Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -4.45% |
| Q3 2025 | 7.67% |
| Q2 2025 | -25.46% |
| Q1 2025 | 7.49% |
| Q4 2024 | -110.18% |
| Q3 2024 | 1086.20% |
| Q2 2024 | -17.87% |
| Q1 2024 | 15.00% |
| Q4 2023 | -5.05% |
| Q3 2023 | -8.97% |
| Q2 2023 | -3.44% |
| Q1 2023 | -321.81% |
| Q4 2022 | 144.68% |
| Q3 2022 | 10.96% |
| Q2 2022 | 3.13% |
| Q1 2022 | -0.16% |
| Q4 2021 | -7.35% |
| Q3 2021 | -5.67% |
| Q2 2021 | 29.44% |
| Q1 2021 | -21.06% |
| Q4 2020 | 1.34% |
| Q3 2020 | -9.40% |
| Q2 2020 | -124.76% |
| Q1 2020 | 60.67% |
| Q4 2019 | 3.60% |
| Q3 2019 | 3.37% |
| Q2 2019 | -18.04% |
| Q1 2019 | -1.40% |
| Q4 2018 | 3.03% |
| Q3 2018 | -37.70% |
| Q2 2018 | 24.31% |
| Q1 2018 | -2.88% |
| Q4 2017 | -14.45% |
| Q3 2017 | 7.16% |
| Q2 2017 | -25.57% |
| Q1 2017 | -17.14% |
| Q4 2016 | 10.10% |
| Q3 2016 | -12.30% |
| Q2 2016 | -141.20% |
| Q1 2016 | 42.89% |